These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23951897)

  • 1. [Viral and drug-induced liver damage in children with tuberculosis: prevalence, clinical features].
    Borzakova SN; Aksenova VA; Reĭzis AR
    Eksp Klin Gastroenterol; 2013; (1):38-43. PubMed ID: 23951897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
    Marzuki OA; Fauzi AR; Ayoub S; Kamarul Imran M
    Singapore Med J; 2008 Sep; 49(9):688-93. PubMed ID: 18830542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
    Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
    J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibility of differentiating viral and drug-induced hepatitis in tuberculous patients].
    Fomin DKh; Gerasun BA; Gutarevich EA
    Sov Med; 1971 Jun; 34(6):74-8. PubMed ID: 5115455
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity of anti-tuberculosis chemotherapy in patients with liver cirrhosis.
    Shin HJ; Lee HS; Kim YI; Lim SC; Jung JP; Ko YC; Kwon YS
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):347-51. PubMed ID: 24670574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort study.
    Feleke BE; Feleke TE; Adane WG; Girma A
    Virol J; 2020 Jul; 17(1):113. PubMed ID: 32703225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy.
    Mansukhani S; Shah I
    Ann Hepatol; 2012; 11(1):96-9. PubMed ID: 22166567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of childhood tuberculosis: consensus statement of IAP Working Group.
    Amdekar YK
    Indian Pediatr; 1998 Dec; 35(12):1263-4. PubMed ID: 10216716
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States.
    Patel PA; Voigt MD
    Am J Gastroenterol; 2002 May; 97(5):1198-203. PubMed ID: 12014728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring liver function among patients who initiated anti-tuberculosis drugs in Taiwan, 2000-2011.
    Chou HC; Lin SW; Chen WW; Ke WM; Chao PH; Hsiao FY
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1245-51. PubMed ID: 25216841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity.
    Sarda P; Sharma SK; Mohan A; Makharia G; Jayaswal A; Pandey RM; Singh S
    Indian J Med Res; 2009 Jan; 129(1):64-7. PubMed ID: 19287059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment.
    Chien JY; Huang RM; Wang JY; Ruan SY; Chien YJ; Yu CJ; Yang PC
    Int J Tuberc Lung Dis; 2010 May; 14(5):616-21. PubMed ID: 20392356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology.
    Heringlake S; Schütte A; Flemming P; Schmiegel W; Manns MP; Tillmann HL
    Z Gastroenterol; 2009 May; 47(5):417-23. PubMed ID: 19418409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An official ATS statement: hepatotoxicity of antituberculosis therapy.
    Saukkonen JJ; Cohn DL; Jasmer RM; Schenker S; Jereb JA; Nolan CM; Peloquin CA; Gordin FM; Nunes D; Strader DB; Bernardo J; Venkataramanan R; Sterling TR;
    Am J Respir Crit Care Med; 2006 Oct; 174(8):935-52. PubMed ID: 17021358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antituberculosis treatment and hepatotoxicity in patients with chronic viral hepatitis.
    Liu YM; Cheng YJ; Li YL; Liu CE; Hsu WH
    Lung; 2014 Feb; 192(1):205-10. PubMed ID: 24292367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of scheduled monitoring of liver function during anti-Tuberculosis treatment in a retrospective cohort in China.
    Wu S; Xia Y; Lv X; Zhang Y; Tang S; Yang Z; Tu D; Deng P; Cheng S; Wang X; Yuan Y; Liu F; Hu D; Zhan S
    BMC Public Health; 2012 Jun; 12():454. PubMed ID: 22712786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.